8-K

Company

OnKure Therapeutics, Inc.

Filed

October 8, 2024

Period of Report

October 4, 2024

Accession Number

0001193125-24-234487

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →